Global Analgesic and Anti-inflammatory API Market Growth 2025-2031
The global Analgesic and Anti-inflammatory API market size is predicted to grow from US$ 769 million in 2025 to US$ 987 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.
Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Analgesic and Anti-inflammatory API Industry Forecast” looks at past sales and reviews total world Analgesic and Anti-inflammatory API sales in 2024, providing a comprehensive analysis by region and market sector of projected Analgesic and Anti-inflammatory API sales for 2025 through 2031. With Analgesic and Anti-inflammatory API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Analgesic and Anti-inflammatory API industry.
This Insight Report provides a comprehensive analysis of the global Analgesic and Anti-inflammatory API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Analgesic and Anti-inflammatory API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Analgesic and Anti-inflammatory API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Analgesic and Anti-inflammatory API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Analgesic and Anti-inflammatory API.
This report presents a comprehensive overview, market shares, and growth opportunities of Analgesic and Anti-inflammatory API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Analgesic and Anti-inflammatory API market?
What factors are driving Analgesic and Anti-inflammatory API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Analgesic and Anti-inflammatory API market opportunities vary by end market size?
How does Analgesic and Anti-inflammatory API break out by Type, by Application?
Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Analgesic and Anti-inflammatory API Industry Forecast” looks at past sales and reviews total world Analgesic and Anti-inflammatory API sales in 2024, providing a comprehensive analysis by region and market sector of projected Analgesic and Anti-inflammatory API sales for 2025 through 2031. With Analgesic and Anti-inflammatory API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Analgesic and Anti-inflammatory API industry.
This Insight Report provides a comprehensive analysis of the global Analgesic and Anti-inflammatory API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Analgesic and Anti-inflammatory API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Analgesic and Anti-inflammatory API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Analgesic and Anti-inflammatory API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Analgesic and Anti-inflammatory API.
This report presents a comprehensive overview, market shares, and growth opportunities of Analgesic and Anti-inflammatory API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ibuprofen
- Paracetamol
- Aspirin
- Naproxen
- Diclofenac
- Oxaprozin
- Dexibuprofen
- Others
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IOL
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical
- Novacyl
- BASF
- BBCA Group
- Hubei Biocause Group
- Xinhua Pharm
- Granules India Limited
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Hunan Zhongnan Pharmaceutical
- Hebei Jingye Medical Technology
What is the 10-year outlook for the global Analgesic and Anti-inflammatory API market?
What factors are driving Analgesic and Anti-inflammatory API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Analgesic and Anti-inflammatory API market opportunities vary by end market size?
How does Analgesic and Anti-inflammatory API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Analgesic and Anti-inflammatory API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Analgesic and Anti-inflammatory API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Analgesic and Anti-inflammatory API by Country/Region, 2020, 2024 & 2031
2.2 Analgesic and Anti-inflammatory API Segment by Type
2.2.1 Ibuprofen
2.2.2 Paracetamol
2.2.3 Aspirin
2.2.4 Naproxen
2.2.5 Diclofenac
2.2.6 Oxaprozin
2.2.7 Dexibuprofen
2.2.8 Others
2.3 Analgesic and Anti-inflammatory API Sales by Type
2.3.1 Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
2.3.2 Global Analgesic and Anti-inflammatory API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Analgesic and Anti-inflammatory API Sale Price by Type (2020-2025)
2.4 Analgesic and Anti-inflammatory API Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Analgesic and Anti-inflammatory API Sales by Application
2.5.1 Global Analgesic and Anti-inflammatory API Sale Market Share by Application (2020-2025)
2.5.2 Global Analgesic and Anti-inflammatory API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Analgesic and Anti-inflammatory API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Analgesic and Anti-inflammatory API Breakdown Data by Company
3.1.1 Global Analgesic and Anti-inflammatory API Annual Sales by Company (2020-2025)
3.1.2 Global Analgesic and Anti-inflammatory API Sales Market Share by Company (2020-2025)
3.2 Global Analgesic and Anti-inflammatory API Annual Revenue by Company (2020-2025)
3.2.1 Global Analgesic and Anti-inflammatory API Revenue by Company (2020-2025)
3.2.2 Global Analgesic and Anti-inflammatory API Revenue Market Share by Company (2020-2025)
3.3 Global Analgesic and Anti-inflammatory API Sale Price by Company
3.4 Key Manufacturers Analgesic and Anti-inflammatory API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Analgesic and Anti-inflammatory API Product Location Distribution
3.4.2 Players Analgesic and Anti-inflammatory API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANALGESIC AND ANTI-INFLAMMATORY API BY GEOGRAPHIC REGION
4.1 World Historic Analgesic and Anti-inflammatory API Market Size by Geographic Region (2020-2025)
4.1.1 Global Analgesic and Anti-inflammatory API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Analgesic and Anti-inflammatory API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Analgesic and Anti-inflammatory API Market Size by Country/Region (2020-2025)
4.2.1 Global Analgesic and Anti-inflammatory API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Analgesic and Anti-inflammatory API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Analgesic and Anti-inflammatory API Sales Growth
4.4 APAC Analgesic and Anti-inflammatory API Sales Growth
4.5 Europe Analgesic and Anti-inflammatory API Sales Growth
4.6 Middle East & Africa Analgesic and Anti-inflammatory API Sales Growth
5 AMERICAS
5.1 Americas Analgesic and Anti-inflammatory API Sales by Country
5.1.1 Americas Analgesic and Anti-inflammatory API Sales by Country (2020-2025)
5.1.2 Americas Analgesic and Anti-inflammatory API Revenue by Country (2020-2025)
5.2 Americas Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
5.3 Americas Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Analgesic and Anti-inflammatory API Sales by Region
6.1.1 APAC Analgesic and Anti-inflammatory API Sales by Region (2020-2025)
6.1.2 APAC Analgesic and Anti-inflammatory API Revenue by Region (2020-2025)
6.2 APAC Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
6.3 APAC Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Analgesic and Anti-inflammatory API by Country
7.1.1 Europe Analgesic and Anti-inflammatory API Sales by Country (2020-2025)
7.1.2 Europe Analgesic and Anti-inflammatory API Revenue by Country (2020-2025)
7.2 Europe Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
7.3 Europe Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Analgesic and Anti-inflammatory API by Country
8.1.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Analgesic and Anti-inflammatory API Revenue by Country (2020-2025)
8.2 Middle East & Africa Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
8.3 Middle East & Africa Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Analgesic and Anti-inflammatory API
10.3 Manufacturing Process Analysis of Analgesic and Anti-inflammatory API
10.4 Industry Chain Structure of Analgesic and Anti-inflammatory API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Analgesic and Anti-inflammatory API Distributors
11.3 Analgesic and Anti-inflammatory API Customer
12 WORLD FORECAST REVIEW FOR ANALGESIC AND ANTI-INFLAMMATORY API BY GEOGRAPHIC REGION
12.1 Global Analgesic and Anti-inflammatory API Market Size Forecast by Region
12.1.1 Global Analgesic and Anti-inflammatory API Forecast by Region (2026-2031)
12.1.2 Global Analgesic and Anti-inflammatory API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Analgesic and Anti-inflammatory API Forecast by Type (2026-2031)
12.7 Global Analgesic and Anti-inflammatory API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 IOL
13.1.1 IOL Company Information
13.1.2 IOL Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.1.3 IOL Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 IOL Main Business Overview
13.1.5 IOL Latest Developments
13.2 Mallinckrodt Pharmaceuticals
13.2.1 Mallinckrodt Pharmaceuticals Company Information
13.2.2 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.2.5 Mallinckrodt Pharmaceuticals Latest Developments
13.3 Anqiu Lu'an Pharmaceutical
13.3.1 Anqiu Lu'an Pharmaceutical Company Information
13.3.2 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Anqiu Lu'an Pharmaceutical Main Business Overview
13.3.5 Anqiu Lu'an Pharmaceutical Latest Developments
13.4 Novacyl
13.4.1 Novacyl Company Information
13.4.2 Novacyl Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.4.3 Novacyl Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novacyl Main Business Overview
13.4.5 Novacyl Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.5.3 BASF Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 BBCA Group
13.6.1 BBCA Group Company Information
13.6.2 BBCA Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.6.3 BBCA Group Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BBCA Group Main Business Overview
13.6.5 BBCA Group Latest Developments
13.7 Hubei Biocause Group
13.7.1 Hubei Biocause Group Company Information
13.7.2 Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hubei Biocause Group Main Business Overview
13.7.5 Hubei Biocause Group Latest Developments
13.8 Xinhua Pharm
13.8.1 Xinhua Pharm Company Information
13.8.2 Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Xinhua Pharm Main Business Overview
13.8.5 Xinhua Pharm Latest Developments
13.9 Granules India Limited
13.9.1 Granules India Limited Company Information
13.9.2 Granules India Limited Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.9.3 Granules India Limited Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Granules India Limited Main Business Overview
13.9.5 Granules India Limited Latest Developments
13.10 Hebei Jiheng Pharmaceutical
13.10.1 Hebei Jiheng Pharmaceutical Company Information
13.10.2 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hebei Jiheng Pharmaceutical Main Business Overview
13.10.5 Hebei Jiheng Pharmaceutical Latest Developments
13.11 Zhejiang Kangle Pharmaceutical
13.11.1 Zhejiang Kangle Pharmaceutical Company Information
13.11.2 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zhejiang Kangle Pharmaceutical Main Business Overview
13.11.5 Zhejiang Kangle Pharmaceutical Latest Developments
13.12 Hunan Zhongnan Pharmaceutical
13.12.1 Hunan Zhongnan Pharmaceutical Company Information
13.12.2 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hunan Zhongnan Pharmaceutical Main Business Overview
13.12.5 Hunan Zhongnan Pharmaceutical Latest Developments
13.13 Hebei Jingye Medical Technology
13.13.1 Hebei Jingye Medical Technology Company Information
13.13.2 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hebei Jingye Medical Technology Main Business Overview
13.13.5 Hebei Jingye Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Analgesic and Anti-inflammatory API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Analgesic and Anti-inflammatory API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Analgesic and Anti-inflammatory API by Country/Region, 2020, 2024 & 2031
2.2 Analgesic and Anti-inflammatory API Segment by Type
2.2.1 Ibuprofen
2.2.2 Paracetamol
2.2.3 Aspirin
2.2.4 Naproxen
2.2.5 Diclofenac
2.2.6 Oxaprozin
2.2.7 Dexibuprofen
2.2.8 Others
2.3 Analgesic and Anti-inflammatory API Sales by Type
2.3.1 Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
2.3.2 Global Analgesic and Anti-inflammatory API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Analgesic and Anti-inflammatory API Sale Price by Type (2020-2025)
2.4 Analgesic and Anti-inflammatory API Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Analgesic and Anti-inflammatory API Sales by Application
2.5.1 Global Analgesic and Anti-inflammatory API Sale Market Share by Application (2020-2025)
2.5.2 Global Analgesic and Anti-inflammatory API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Analgesic and Anti-inflammatory API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Analgesic and Anti-inflammatory API Breakdown Data by Company
3.1.1 Global Analgesic and Anti-inflammatory API Annual Sales by Company (2020-2025)
3.1.2 Global Analgesic and Anti-inflammatory API Sales Market Share by Company (2020-2025)
3.2 Global Analgesic and Anti-inflammatory API Annual Revenue by Company (2020-2025)
3.2.1 Global Analgesic and Anti-inflammatory API Revenue by Company (2020-2025)
3.2.2 Global Analgesic and Anti-inflammatory API Revenue Market Share by Company (2020-2025)
3.3 Global Analgesic and Anti-inflammatory API Sale Price by Company
3.4 Key Manufacturers Analgesic and Anti-inflammatory API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Analgesic and Anti-inflammatory API Product Location Distribution
3.4.2 Players Analgesic and Anti-inflammatory API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANALGESIC AND ANTI-INFLAMMATORY API BY GEOGRAPHIC REGION
4.1 World Historic Analgesic and Anti-inflammatory API Market Size by Geographic Region (2020-2025)
4.1.1 Global Analgesic and Anti-inflammatory API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Analgesic and Anti-inflammatory API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Analgesic and Anti-inflammatory API Market Size by Country/Region (2020-2025)
4.2.1 Global Analgesic and Anti-inflammatory API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Analgesic and Anti-inflammatory API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Analgesic and Anti-inflammatory API Sales Growth
4.4 APAC Analgesic and Anti-inflammatory API Sales Growth
4.5 Europe Analgesic and Anti-inflammatory API Sales Growth
4.6 Middle East & Africa Analgesic and Anti-inflammatory API Sales Growth
5 AMERICAS
5.1 Americas Analgesic and Anti-inflammatory API Sales by Country
5.1.1 Americas Analgesic and Anti-inflammatory API Sales by Country (2020-2025)
5.1.2 Americas Analgesic and Anti-inflammatory API Revenue by Country (2020-2025)
5.2 Americas Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
5.3 Americas Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Analgesic and Anti-inflammatory API Sales by Region
6.1.1 APAC Analgesic and Anti-inflammatory API Sales by Region (2020-2025)
6.1.2 APAC Analgesic and Anti-inflammatory API Revenue by Region (2020-2025)
6.2 APAC Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
6.3 APAC Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Analgesic and Anti-inflammatory API by Country
7.1.1 Europe Analgesic and Anti-inflammatory API Sales by Country (2020-2025)
7.1.2 Europe Analgesic and Anti-inflammatory API Revenue by Country (2020-2025)
7.2 Europe Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
7.3 Europe Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Analgesic and Anti-inflammatory API by Country
8.1.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Analgesic and Anti-inflammatory API Revenue by Country (2020-2025)
8.2 Middle East & Africa Analgesic and Anti-inflammatory API Sales by Type (2020-2025)
8.3 Middle East & Africa Analgesic and Anti-inflammatory API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Analgesic and Anti-inflammatory API
10.3 Manufacturing Process Analysis of Analgesic and Anti-inflammatory API
10.4 Industry Chain Structure of Analgesic and Anti-inflammatory API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Analgesic and Anti-inflammatory API Distributors
11.3 Analgesic and Anti-inflammatory API Customer
12 WORLD FORECAST REVIEW FOR ANALGESIC AND ANTI-INFLAMMATORY API BY GEOGRAPHIC REGION
12.1 Global Analgesic and Anti-inflammatory API Market Size Forecast by Region
12.1.1 Global Analgesic and Anti-inflammatory API Forecast by Region (2026-2031)
12.1.2 Global Analgesic and Anti-inflammatory API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Analgesic and Anti-inflammatory API Forecast by Type (2026-2031)
12.7 Global Analgesic and Anti-inflammatory API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 IOL
13.1.1 IOL Company Information
13.1.2 IOL Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.1.3 IOL Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 IOL Main Business Overview
13.1.5 IOL Latest Developments
13.2 Mallinckrodt Pharmaceuticals
13.2.1 Mallinckrodt Pharmaceuticals Company Information
13.2.2 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.2.5 Mallinckrodt Pharmaceuticals Latest Developments
13.3 Anqiu Lu'an Pharmaceutical
13.3.1 Anqiu Lu'an Pharmaceutical Company Information
13.3.2 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Anqiu Lu'an Pharmaceutical Main Business Overview
13.3.5 Anqiu Lu'an Pharmaceutical Latest Developments
13.4 Novacyl
13.4.1 Novacyl Company Information
13.4.2 Novacyl Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.4.3 Novacyl Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novacyl Main Business Overview
13.4.5 Novacyl Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.5.3 BASF Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 BBCA Group
13.6.1 BBCA Group Company Information
13.6.2 BBCA Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.6.3 BBCA Group Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BBCA Group Main Business Overview
13.6.5 BBCA Group Latest Developments
13.7 Hubei Biocause Group
13.7.1 Hubei Biocause Group Company Information
13.7.2 Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hubei Biocause Group Main Business Overview
13.7.5 Hubei Biocause Group Latest Developments
13.8 Xinhua Pharm
13.8.1 Xinhua Pharm Company Information
13.8.2 Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Xinhua Pharm Main Business Overview
13.8.5 Xinhua Pharm Latest Developments
13.9 Granules India Limited
13.9.1 Granules India Limited Company Information
13.9.2 Granules India Limited Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.9.3 Granules India Limited Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Granules India Limited Main Business Overview
13.9.5 Granules India Limited Latest Developments
13.10 Hebei Jiheng Pharmaceutical
13.10.1 Hebei Jiheng Pharmaceutical Company Information
13.10.2 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hebei Jiheng Pharmaceutical Main Business Overview
13.10.5 Hebei Jiheng Pharmaceutical Latest Developments
13.11 Zhejiang Kangle Pharmaceutical
13.11.1 Zhejiang Kangle Pharmaceutical Company Information
13.11.2 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zhejiang Kangle Pharmaceutical Main Business Overview
13.11.5 Zhejiang Kangle Pharmaceutical Latest Developments
13.12 Hunan Zhongnan Pharmaceutical
13.12.1 Hunan Zhongnan Pharmaceutical Company Information
13.12.2 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hunan Zhongnan Pharmaceutical Main Business Overview
13.12.5 Hunan Zhongnan Pharmaceutical Latest Developments
13.13 Hebei Jingye Medical Technology
13.13.1 Hebei Jingye Medical Technology Company Information
13.13.2 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolios and Specifications
13.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hebei Jingye Medical Technology Main Business Overview
13.13.5 Hebei Jingye Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Analgesic and Anti-inflammatory API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Analgesic and Anti-inflammatory API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ibuprofen
Table 4. Major Players of Paracetamol
Table 5. Major Players of Aspirin
Table 6. Major Players of Naproxen
Table 7. Major Players of Diclofenac
Table 8. Major Players of Oxaprozin
Table 9. Major Players of Dexibuprofen
Table 10. Major Players of Others
Table 11. Global Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 12. Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Table 13. Global Analgesic and Anti-inflammatory API Revenue by Type (2020-2025) & ($ million)
Table 14. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2020-2025)
Table 15. Global Analgesic and Anti-inflammatory API Sale Price by Type (2020-2025) & (US$/Ton)
Table 16. Global Analgesic and Anti-inflammatory API Sale by Application (2020-2025) & (Tons)
Table 17. Global Analgesic and Anti-inflammatory API Sale Market Share by Application (2020-2025)
Table 18. Global Analgesic and Anti-inflammatory API Revenue by Application (2020-2025) & ($ million)
Table 19. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application (2020-2025)
Table 20. Global Analgesic and Anti-inflammatory API Sale Price by Application (2020-2025) & (US$/Ton)
Table 21. Global Analgesic and Anti-inflammatory API Sales by Company (2020-2025) & (Tons)
Table 22. Global Analgesic and Anti-inflammatory API Sales Market Share by Company (2020-2025)
Table 23. Global Analgesic and Anti-inflammatory API Revenue by Company (2020-2025) & ($ millions)
Table 24. Global Analgesic and Anti-inflammatory API Revenue Market Share by Company (2020-2025)
Table 25. Global Analgesic and Anti-inflammatory API Sale Price by Company (2020-2025) & (US$/Ton)
Table 26. Key Manufacturers Analgesic and Anti-inflammatory API Producing Area Distribution and Sales Area
Table 27. Players Analgesic and Anti-inflammatory API Products Offered
Table 28. Analgesic and Anti-inflammatory API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 29. New Products and Potential Entrants
Table 30. Market M&A Activity & Strategy
Table 31. Global Analgesic and Anti-inflammatory API Sales by Geographic Region (2020-2025) & (Tons)
Table 32. Global Analgesic and Anti-inflammatory API Sales Market Share Geographic Region (2020-2025)
Table 33. Global Analgesic and Anti-inflammatory API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 34. Global Analgesic and Anti-inflammatory API Revenue Market Share by Geographic Region (2020-2025)
Table 35. Global Analgesic and Anti-inflammatory API Sales by Country/Region (2020-2025) & (Tons)
Table 36. Global Analgesic and Anti-inflammatory API Sales Market Share by Country/Region (2020-2025)
Table 37. Global Analgesic and Anti-inflammatory API Revenue by Country/Region (2020-2025) & ($ millions)
Table 38. Global Analgesic and Anti-inflammatory API Revenue Market Share by Country/Region (2020-2025)
Table 39. Americas Analgesic and Anti-inflammatory API Sales by Country (2020-2025) & (Tons)
Table 40. Americas Analgesic and Anti-inflammatory API Sales Market Share by Country (2020-2025)
Table 41. Americas Analgesic and Anti-inflammatory API Revenue by Country (2020-2025) & ($ millions)
Table 42. Americas Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 43. Americas Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 44. APAC Analgesic and Anti-inflammatory API Sales by Region (2020-2025) & (Tons)
Table 45. APAC Analgesic and Anti-inflammatory API Sales Market Share by Region (2020-2025)
Table 46. APAC Analgesic and Anti-inflammatory API Revenue by Region (2020-2025) & ($ millions)
Table 47. APAC Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 48. APAC Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 49. Europe Analgesic and Anti-inflammatory API Sales by Country (2020-2025) & (Tons)
Table 50. Europe Analgesic and Anti-inflammatory API Revenue by Country (2020-2025) & ($ millions)
Table 51. Europe Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 52. Europe Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 53. Middle East & Africa Analgesic and Anti-inflammatory API Sales by Country (2020-2025) & (Tons)
Table 54. Middle East & Africa Analgesic and Anti-inflammatory API Revenue Market Share by Country (2020-2025)
Table 55. Middle East & Africa Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 56. Middle East & Africa Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Analgesic and Anti-inflammatory API
Table 58. Key Market Challenges & Risks of Analgesic and Anti-inflammatory API
Table 59. Key Industry Trends of Analgesic and Anti-inflammatory API
Table 60. Analgesic and Anti-inflammatory API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Analgesic and Anti-inflammatory API Distributors List
Table 63. Analgesic and Anti-inflammatory API Customer List
Table 64. Global Analgesic and Anti-inflammatory API Sales Forecast by Region (2026-2031) & (Tons)
Table 65. Global Analgesic and Anti-inflammatory API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Americas Analgesic and Anti-inflammatory API Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Americas Analgesic and Anti-inflammatory API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. APAC Analgesic and Anti-inflammatory API Sales Forecast by Region (2026-2031) & (Tons)
Table 69. APAC Analgesic and Anti-inflammatory API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 70. Europe Analgesic and Anti-inflammatory API Sales Forecast by Country (2026-2031) & (Tons)
Table 71. Europe Analgesic and Anti-inflammatory API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Middle East & Africa Analgesic and Anti-inflammatory API Sales Forecast by Country (2026-2031) & (Tons)
Table 73. Middle East & Africa Analgesic and Anti-inflammatory API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 74. Global Analgesic and Anti-inflammatory API Sales Forecast by Type (2026-2031) & (Tons)
Table 75. Global Analgesic and Anti-inflammatory API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 76. Global Analgesic and Anti-inflammatory API Sales Forecast by Application (2026-2031) & (Tons)
Table 77. Global Analgesic and Anti-inflammatory API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 78. IOL Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 79. IOL Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 80. IOL Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 81. IOL Main Business
Table 82. IOL Latest Developments
Table 83. Mallinckrodt Pharmaceuticals Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 84. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 85. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 86. Mallinckrodt Pharmaceuticals Main Business
Table 87. Mallinckrodt Pharmaceuticals Latest Developments
Table 88. Anqiu Lu'an Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 89. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 90. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 91. Anqiu Lu'an Pharmaceutical Main Business
Table 92. Anqiu Lu'an Pharmaceutical Latest Developments
Table 93. Novacyl Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 94. Novacyl Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 95. Novacyl Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 96. Novacyl Main Business
Table 97. Novacyl Latest Developments
Table 98. BASF Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 99. BASF Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 100. BASF Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 101. BASF Main Business
Table 102. BASF Latest Developments
Table 103. BBCA Group Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 104. BBCA Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 105. BBCA Group Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 106. BBCA Group Main Business
Table 107. BBCA Group Latest Developments
Table 108. Hubei Biocause Group Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 109. Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 110. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 111. Hubei Biocause Group Main Business
Table 112. Hubei Biocause Group Latest Developments
Table 113. Xinhua Pharm Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 114. Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 115. Xinhua Pharm Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 116. Xinhua Pharm Main Business
Table 117. Xinhua Pharm Latest Developments
Table 118. Granules India Limited Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 119. Granules India Limited Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 120. Granules India Limited Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 121. Granules India Limited Main Business
Table 122. Granules India Limited Latest Developments
Table 123. Hebei Jiheng Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 125. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 126. Hebei Jiheng Pharmaceutical Main Business
Table 127. Hebei Jiheng Pharmaceutical Latest Developments
Table 128. Zhejiang Kangle Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 129. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 130. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 131. Zhejiang Kangle Pharmaceutical Main Business
Table 132. Zhejiang Kangle Pharmaceutical Latest Developments
Table 133. Hunan Zhongnan Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 135. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 136. Hunan Zhongnan Pharmaceutical Main Business
Table 137. Hunan Zhongnan Pharmaceutical Latest Developments
Table 138. Hebei Jingye Medical Technology Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 139. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 140. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 141. Hebei Jingye Medical Technology Main Business
Table 142. Hebei Jingye Medical Technology Latest Developments
Table 1. Analgesic and Anti-inflammatory API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Analgesic and Anti-inflammatory API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ibuprofen
Table 4. Major Players of Paracetamol
Table 5. Major Players of Aspirin
Table 6. Major Players of Naproxen
Table 7. Major Players of Diclofenac
Table 8. Major Players of Oxaprozin
Table 9. Major Players of Dexibuprofen
Table 10. Major Players of Others
Table 11. Global Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 12. Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Table 13. Global Analgesic and Anti-inflammatory API Revenue by Type (2020-2025) & ($ million)
Table 14. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2020-2025)
Table 15. Global Analgesic and Anti-inflammatory API Sale Price by Type (2020-2025) & (US$/Ton)
Table 16. Global Analgesic and Anti-inflammatory API Sale by Application (2020-2025) & (Tons)
Table 17. Global Analgesic and Anti-inflammatory API Sale Market Share by Application (2020-2025)
Table 18. Global Analgesic and Anti-inflammatory API Revenue by Application (2020-2025) & ($ million)
Table 19. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application (2020-2025)
Table 20. Global Analgesic and Anti-inflammatory API Sale Price by Application (2020-2025) & (US$/Ton)
Table 21. Global Analgesic and Anti-inflammatory API Sales by Company (2020-2025) & (Tons)
Table 22. Global Analgesic and Anti-inflammatory API Sales Market Share by Company (2020-2025)
Table 23. Global Analgesic and Anti-inflammatory API Revenue by Company (2020-2025) & ($ millions)
Table 24. Global Analgesic and Anti-inflammatory API Revenue Market Share by Company (2020-2025)
Table 25. Global Analgesic and Anti-inflammatory API Sale Price by Company (2020-2025) & (US$/Ton)
Table 26. Key Manufacturers Analgesic and Anti-inflammatory API Producing Area Distribution and Sales Area
Table 27. Players Analgesic and Anti-inflammatory API Products Offered
Table 28. Analgesic and Anti-inflammatory API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 29. New Products and Potential Entrants
Table 30. Market M&A Activity & Strategy
Table 31. Global Analgesic and Anti-inflammatory API Sales by Geographic Region (2020-2025) & (Tons)
Table 32. Global Analgesic and Anti-inflammatory API Sales Market Share Geographic Region (2020-2025)
Table 33. Global Analgesic and Anti-inflammatory API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 34. Global Analgesic and Anti-inflammatory API Revenue Market Share by Geographic Region (2020-2025)
Table 35. Global Analgesic and Anti-inflammatory API Sales by Country/Region (2020-2025) & (Tons)
Table 36. Global Analgesic and Anti-inflammatory API Sales Market Share by Country/Region (2020-2025)
Table 37. Global Analgesic and Anti-inflammatory API Revenue by Country/Region (2020-2025) & ($ millions)
Table 38. Global Analgesic and Anti-inflammatory API Revenue Market Share by Country/Region (2020-2025)
Table 39. Americas Analgesic and Anti-inflammatory API Sales by Country (2020-2025) & (Tons)
Table 40. Americas Analgesic and Anti-inflammatory API Sales Market Share by Country (2020-2025)
Table 41. Americas Analgesic and Anti-inflammatory API Revenue by Country (2020-2025) & ($ millions)
Table 42. Americas Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 43. Americas Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 44. APAC Analgesic and Anti-inflammatory API Sales by Region (2020-2025) & (Tons)
Table 45. APAC Analgesic and Anti-inflammatory API Sales Market Share by Region (2020-2025)
Table 46. APAC Analgesic and Anti-inflammatory API Revenue by Region (2020-2025) & ($ millions)
Table 47. APAC Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 48. APAC Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 49. Europe Analgesic and Anti-inflammatory API Sales by Country (2020-2025) & (Tons)
Table 50. Europe Analgesic and Anti-inflammatory API Revenue by Country (2020-2025) & ($ millions)
Table 51. Europe Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 52. Europe Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 53. Middle East & Africa Analgesic and Anti-inflammatory API Sales by Country (2020-2025) & (Tons)
Table 54. Middle East & Africa Analgesic and Anti-inflammatory API Revenue Market Share by Country (2020-2025)
Table 55. Middle East & Africa Analgesic and Anti-inflammatory API Sales by Type (2020-2025) & (Tons)
Table 56. Middle East & Africa Analgesic and Anti-inflammatory API Sales by Application (2020-2025) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Analgesic and Anti-inflammatory API
Table 58. Key Market Challenges & Risks of Analgesic and Anti-inflammatory API
Table 59. Key Industry Trends of Analgesic and Anti-inflammatory API
Table 60. Analgesic and Anti-inflammatory API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Analgesic and Anti-inflammatory API Distributors List
Table 63. Analgesic and Anti-inflammatory API Customer List
Table 64. Global Analgesic and Anti-inflammatory API Sales Forecast by Region (2026-2031) & (Tons)
Table 65. Global Analgesic and Anti-inflammatory API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Americas Analgesic and Anti-inflammatory API Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Americas Analgesic and Anti-inflammatory API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. APAC Analgesic and Anti-inflammatory API Sales Forecast by Region (2026-2031) & (Tons)
Table 69. APAC Analgesic and Anti-inflammatory API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 70. Europe Analgesic and Anti-inflammatory API Sales Forecast by Country (2026-2031) & (Tons)
Table 71. Europe Analgesic and Anti-inflammatory API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Middle East & Africa Analgesic and Anti-inflammatory API Sales Forecast by Country (2026-2031) & (Tons)
Table 73. Middle East & Africa Analgesic and Anti-inflammatory API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 74. Global Analgesic and Anti-inflammatory API Sales Forecast by Type (2026-2031) & (Tons)
Table 75. Global Analgesic and Anti-inflammatory API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 76. Global Analgesic and Anti-inflammatory API Sales Forecast by Application (2026-2031) & (Tons)
Table 77. Global Analgesic and Anti-inflammatory API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 78. IOL Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 79. IOL Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 80. IOL Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 81. IOL Main Business
Table 82. IOL Latest Developments
Table 83. Mallinckrodt Pharmaceuticals Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 84. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 85. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 86. Mallinckrodt Pharmaceuticals Main Business
Table 87. Mallinckrodt Pharmaceuticals Latest Developments
Table 88. Anqiu Lu'an Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 89. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 90. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 91. Anqiu Lu'an Pharmaceutical Main Business
Table 92. Anqiu Lu'an Pharmaceutical Latest Developments
Table 93. Novacyl Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 94. Novacyl Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 95. Novacyl Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 96. Novacyl Main Business
Table 97. Novacyl Latest Developments
Table 98. BASF Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 99. BASF Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 100. BASF Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 101. BASF Main Business
Table 102. BASF Latest Developments
Table 103. BBCA Group Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 104. BBCA Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 105. BBCA Group Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 106. BBCA Group Main Business
Table 107. BBCA Group Latest Developments
Table 108. Hubei Biocause Group Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 109. Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 110. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 111. Hubei Biocause Group Main Business
Table 112. Hubei Biocause Group Latest Developments
Table 113. Xinhua Pharm Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 114. Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 115. Xinhua Pharm Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 116. Xinhua Pharm Main Business
Table 117. Xinhua Pharm Latest Developments
Table 118. Granules India Limited Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 119. Granules India Limited Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 120. Granules India Limited Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 121. Granules India Limited Main Business
Table 122. Granules India Limited Latest Developments
Table 123. Hebei Jiheng Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 125. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 126. Hebei Jiheng Pharmaceutical Main Business
Table 127. Hebei Jiheng Pharmaceutical Latest Developments
Table 128. Zhejiang Kangle Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 129. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 130. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 131. Zhejiang Kangle Pharmaceutical Main Business
Table 132. Zhejiang Kangle Pharmaceutical Latest Developments
Table 133. Hunan Zhongnan Pharmaceutical Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 135. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 136. Hunan Zhongnan Pharmaceutical Main Business
Table 137. Hunan Zhongnan Pharmaceutical Latest Developments
Table 138. Hebei Jingye Medical Technology Basic Information, Analgesic and Anti-inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 139. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolios and Specifications
Table 140. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 141. Hebei Jingye Medical Technology Main Business
Table 142. Hebei Jingye Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Analgesic and Anti-inflammatory API
Figure 2. Analgesic and Anti-inflammatory API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Analgesic and Anti-inflammatory API Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Analgesic and Anti-inflammatory API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Analgesic and Anti-inflammatory API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Analgesic and Anti-inflammatory API Sales Market Share by Country/Region (2024)
Figure 10. Analgesic and Anti-inflammatory API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ibuprofen
Figure 12. Product Picture of Paracetamol
Figure 13. Product Picture of Aspirin
Figure 14. Product Picture of Naproxen
Figure 15. Product Picture of Diclofenac
Figure 16. Product Picture of Oxaprozin
Figure 17. Product Picture of Dexibuprofen
Figure 18. Product Picture of Others
Figure 19. Global Analgesic and Anti-inflammatory API Sales Market Share by Type in 2025
Figure 20. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2020-2025)
Figure 21. Analgesic and Anti-inflammatory API Consumed in Adults
Figure 22. Global Analgesic and Anti-inflammatory API Market: Adults (2020-2025) & (Tons)
Figure 23. Analgesic and Anti-inflammatory API Consumed in Children
Figure 24. Global Analgesic and Anti-inflammatory API Market: Children (2020-2025) & (Tons)
Figure 25. Global Analgesic and Anti-inflammatory API Sale Market Share by Application (2024)
Figure 26. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application in 2025
Figure 27. Analgesic and Anti-inflammatory API Sales by Company in 2025 (Tons)
Figure 28. Global Analgesic and Anti-inflammatory API Sales Market Share by Company in 2025
Figure 29. Analgesic and Anti-inflammatory API Revenue by Company in 2025 ($ millions)
Figure 30. Global Analgesic and Anti-inflammatory API Revenue Market Share by Company in 2025
Figure 31. Global Analgesic and Anti-inflammatory API Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Analgesic and Anti-inflammatory API Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 34. Americas Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 35. APAC Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 36. APAC Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 37. Europe Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 38. Europe Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 40. Middle East & Africa Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 41. Americas Analgesic and Anti-inflammatory API Sales Market Share by Country in 2025
Figure 42. Americas Analgesic and Anti-inflammatory API Revenue Market Share by Country (2020-2025)
Figure 43. Americas Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 44. Americas Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 45. United States Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Analgesic and Anti-inflammatory API Sales Market Share by Region in 2025
Figure 50. APAC Analgesic and Anti-inflammatory API Revenue Market Share by Region (2020-2025)
Figure 51. APAC Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 52. APAC Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 53. China Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 57. India Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Analgesic and Anti-inflammatory API Sales Market Share by Country in 2025
Figure 61. Europe Analgesic and Anti-inflammatory API Revenue Market Share by Country (2020-2025)
Figure 62. Europe Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 63. Europe Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 64. Germany Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 65. France Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Analgesic and Anti-inflammatory API Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 72. Egypt Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Analgesic and Anti-inflammatory API in 2025
Figure 78. Manufacturing Process Analysis of Analgesic and Anti-inflammatory API
Figure 79. Industry Chain Structure of Analgesic and Anti-inflammatory API
Figure 80. Channels of Distribution
Figure 81. Global Analgesic and Anti-inflammatory API Sales Market Forecast by Region (2026-2031)
Figure 82. Global Analgesic and Anti-inflammatory API Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Analgesic and Anti-inflammatory API Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Analgesic and Anti-inflammatory API Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Analgesic and Anti-inflammatory API Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Analgesic and Anti-inflammatory API Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Analgesic and Anti-inflammatory API
Figure 2. Analgesic and Anti-inflammatory API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Analgesic and Anti-inflammatory API Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Analgesic and Anti-inflammatory API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Analgesic and Anti-inflammatory API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Analgesic and Anti-inflammatory API Sales Market Share by Country/Region (2024)
Figure 10. Analgesic and Anti-inflammatory API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ibuprofen
Figure 12. Product Picture of Paracetamol
Figure 13. Product Picture of Aspirin
Figure 14. Product Picture of Naproxen
Figure 15. Product Picture of Diclofenac
Figure 16. Product Picture of Oxaprozin
Figure 17. Product Picture of Dexibuprofen
Figure 18. Product Picture of Others
Figure 19. Global Analgesic and Anti-inflammatory API Sales Market Share by Type in 2025
Figure 20. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2020-2025)
Figure 21. Analgesic and Anti-inflammatory API Consumed in Adults
Figure 22. Global Analgesic and Anti-inflammatory API Market: Adults (2020-2025) & (Tons)
Figure 23. Analgesic and Anti-inflammatory API Consumed in Children
Figure 24. Global Analgesic and Anti-inflammatory API Market: Children (2020-2025) & (Tons)
Figure 25. Global Analgesic and Anti-inflammatory API Sale Market Share by Application (2024)
Figure 26. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application in 2025
Figure 27. Analgesic and Anti-inflammatory API Sales by Company in 2025 (Tons)
Figure 28. Global Analgesic and Anti-inflammatory API Sales Market Share by Company in 2025
Figure 29. Analgesic and Anti-inflammatory API Revenue by Company in 2025 ($ millions)
Figure 30. Global Analgesic and Anti-inflammatory API Revenue Market Share by Company in 2025
Figure 31. Global Analgesic and Anti-inflammatory API Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Analgesic and Anti-inflammatory API Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 34. Americas Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 35. APAC Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 36. APAC Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 37. Europe Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 38. Europe Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Analgesic and Anti-inflammatory API Sales 2020-2025 (Tons)
Figure 40. Middle East & Africa Analgesic and Anti-inflammatory API Revenue 2020-2025 ($ millions)
Figure 41. Americas Analgesic and Anti-inflammatory API Sales Market Share by Country in 2025
Figure 42. Americas Analgesic and Anti-inflammatory API Revenue Market Share by Country (2020-2025)
Figure 43. Americas Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 44. Americas Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 45. United States Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Analgesic and Anti-inflammatory API Sales Market Share by Region in 2025
Figure 50. APAC Analgesic and Anti-inflammatory API Revenue Market Share by Region (2020-2025)
Figure 51. APAC Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 52. APAC Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 53. China Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 57. India Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Analgesic and Anti-inflammatory API Sales Market Share by Country in 2025
Figure 61. Europe Analgesic and Anti-inflammatory API Revenue Market Share by Country (2020-2025)
Figure 62. Europe Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 63. Europe Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 64. Germany Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 65. France Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Analgesic and Anti-inflammatory API Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Analgesic and Anti-inflammatory API Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Analgesic and Anti-inflammatory API Sales Market Share by Application (2020-2025)
Figure 72. Egypt Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Analgesic and Anti-inflammatory API Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Analgesic and Anti-inflammatory API in 2025
Figure 78. Manufacturing Process Analysis of Analgesic and Anti-inflammatory API
Figure 79. Industry Chain Structure of Analgesic and Anti-inflammatory API
Figure 80. Channels of Distribution
Figure 81. Global Analgesic and Anti-inflammatory API Sales Market Forecast by Region (2026-2031)
Figure 82. Global Analgesic and Anti-inflammatory API Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Analgesic and Anti-inflammatory API Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Analgesic and Anti-inflammatory API Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Analgesic and Anti-inflammatory API Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Analgesic and Anti-inflammatory API Revenue Market Share Forecast by Application (2026-2031)
